The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...

The FDA has updated the label indication for linaclotide capsules for the treatment of irritable bowel syndrome with ...

Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...

Around a third of children in the UK will experience some form of constipation - but what is it, and how can you help?

FDA approves IBS drug for children, Linzess, to treat pediatric IBS-C in patients ages 7 and older with proven safety and efficacy.

The FDA has approved Linzess (linaclotide) for children aged 7 and older with IBS-C, marking the first FDA-approved drug for ...

SUNDAY, Sept. 21, 2025 (HealthDay News) — When a child struggles with constipation, it can be a source of frustration and discomfort for the whole family. But a leading pediatric expert offers a clear ...

Mar. 23 -- (HealthDay News) -- Children are considered constipated if they have fewer than three bowel movements a week, or their stools are large, hard, and difficult to pass. Here are suggestions ...

The US medicines regulator has approved Linzess (linaclotide) capsules for children aged seven years and older with irritable ...